Title: Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence.
Journal: The international journal of biochemistry & cell biology 20120301
Title: Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells.
Journal: PloS one 20120101
Title: Mortalin inhibition in experimental Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20110801
Title: Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Journal: International journal of cancer 20100315
Title: Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL).
Journal: Journal of medicinal chemistry 20100114
Title: The selective in vitro cytotoxicity of carcinoma cells by AZT is enhanced by concurrent treatment with delocalized lipophilic cations.
Journal: Cancer letters 20030730
Title: Potentiation of the antiproliferative activity of MKT-077 by loperamide, diltiazem and tamoxifen.
Journal: Oncology reports 20030101
Title: Mortalin: a potential candidate for biotechnology and biomedicine.
Journal: Histology and histopathology 20021001
Title: Starenki D, et al. Selective Mitochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and In Vivo. Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603.
Title: Li X, et al. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. ACS Med Chem Lett. 2013 Nov 14;4(11).
Title: Weisberg EL, et al. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 1996 Feb 1;56(3):551-5.
